Navigation Links
SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Spain
Date:6/24/2009

rs of endoscopes which are used in conjunction with our product."

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-K and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-K and other documents.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provides the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. In addition, the Company's LUMA(R) Cervical Imaging technology has received FDA approval as an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available today.

    Contact:

    SpectraScience, Inc.                         Hayden Communications
    Jim Hi
'/>"/>
SOURCE SpectraScience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. SpectraScience Receives FDA Clearance for Manufacturing Facility
2. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus
3. SpectraScience, Inc. Enters Into $6.0 Million Common Stock Purchase Agreement
4. SpectraScience Announces Business Update
5. SpectraScience Awarded U.S. Patent 7,469,160 for Its Unique Methods and Apparatus for Evaluating Image Focus
6. SpectraScience Awarded U.S. Patent 7,459,696 for its Unique Methods of Calibrating Spectral Data
7. SpectraScience Awarded European Patent for Its Optical Biopsy System for Tissue Diagnosis
8. SpectraScience Announces Updates
9. SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients
10. SpectraScience Awarded Patent for Correcting Image Misalignment
11. SpectraScience Adds Industry Veteran to Executive Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... As a result of C3: Colorectal Cancer ... reviewed cancer research program is included in the final ... new cancer research program will research cancers, like colorectal ... lung and ovarian cancer research programs run by the ... ,, The $15 million in funding for this new ...
(Date:12/16/2009)... Sanger Institute announce the first comprehensive analyses of cancer ... in the DNA of cancer cells which are acquired ... melanoma and a lung cancer, reveal for the first ... two cancers. , Lung cancer causes around one million ... smoking. The number of mutations found suggest that a ...
(Date:12/16/2009)... Cost-Effective Care , ... Washington, D.C. (Vocus) December 16, ... ways to rein in runaway costs while providing care to all ... the ongoing discussion includes how to ensure patients equal access to ... (MDs) or osteopathy (DOs). In both the House and Senate ...
(Date:12/16/2009)... annual marketing campaign , ... Englewood, ... 2010 Genetown™ Hotbed Campaign as its largest yearly promotion ... by MassBio and showcases 37 Massachusetts companies across ... entity’s brand on an electronic and printed map ...
(Date:12/16/2009)... Technologies, Inc., developers of the AcceleDent System ... orthodontics, announced Alison Davies as its new Director ... has spent the last fourteen years of her ... for nine years as a senior manager with ... . ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO ) ...
Breaking Medicine News(10 mins):Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5Health News:Thriving Bioscience Region Leaves Its Mark 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4
... Living Inc.,(NYSE: BKD ) announced today that it ... financial results after the market closes on Wednesday,February 27, ... discuss,the results on February 28, 2008 at 10:00 AM ... 845-7252 (from within the U.S.) or (706) 634-9069,(from outside ...
... Institute have collaborated on a major advance in understanding a ... in humans. The culmination of 10 years work, their research ... , During much of its lifetime, the DNA that ... form, stored inside densely knotted structures in the cell nucleus. ...
... to close FMLA loopholes, ALEXANDRIA, Va., Feb. ... devoted to human resource management,appeared before a Senate ... the,Family Medical and Leave Act (FMLA) be closed., ... have two primary concerns with the act,s,regulations--the definitions ...
... further convinces Accipiter that ... YORK, Feb. 13 Accipiter Capital Management, the,owner, together ... of common stock of VistaCare, Inc. (Nasdaq: VSTA ... VistaCare,s Board of Directors stating,that a review of VistaCare,s ...
... can lead to higher levels of severe post-natal depression (PND) and ... published in the February issue of Journal of Clinical Nursing. , ... Universite Nancy 2, France, found that just under a third of ... had PND. , Nine per cent of the women in ...
... SCI ), which owns and operates funeral service,locations and ... a quarterly cash dividend of four cents per share ... payable on April 30, 2008 to,shareholders of record at ... Company intends to pay regular quarterly cash dividends for ...
Other Medicine News:Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Release and Earnings Call 2Health News:Scientists solve structure of gene regulator that plays key role in cancer 2Health News:Scientists solve structure of gene regulator that plays key role in cancer 3Health News:Is a Common Cold a 'Serious Health Condition'? 2Health News:Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 2Health News:Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 3Health News:Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 4Health News:Male births are more likely to reduce quality of life and increase severe post-natal depression 2Health News:Male births are more likely to reduce quality of life and increase severe post-natal depression 3Health News:Service Corporation International Declares Quarterly Cash Dividend 2Health News:Service Corporation International Declares Quarterly Cash Dividend 3
(Date:12/16/2009)... Tenn. , Dec. 16 MedSolutions ... cost management services, today commended two new studies ... CT scans and other diagnostic imaging tests. ... to proper diagnosis and treatment," said Gregg Allen, ... new studies offer more compelling evidence that stricter ...
(Date:12/16/2009)... WALTHAM, Mass., Dec. 16 According to ... medical technology market intelligence, although the US minimally ... compound annual growth rate of over 12% through ... growth in the overall market, which previously had ... US Markets for Minimally Invasive Spine Technologies 2010 ...
(Date:12/16/2009)... -- Medlytix, a national healthcare consulting firm, reported ... dollar milestone - the total amount of money ... assistance to more than a half-million patients nationwide ... charity care - in less than two years. ... enhanced their bottom lines and still were able ...
Breaking Medicine Technology:MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 2Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 3Healthcare Scoring System Allows Hospitals To Increase Charity Care 2Healthcare Scoring System Allows Hospitals To Increase Charity Care 3Healthcare Scoring System Allows Hospitals To Increase Charity Care 4Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date 13246 1Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date 13246 2Hospira Reports Second Quarter 2009 Results 53042 1Hospira Reports Second Quarter 2009 Results 53042 2Hospira Reports Second Quarter 2009 Results 53042 3Hospira Reports Second Quarter 2009 Results 53042 4Hospira Reports Second Quarter 2009 Results 53042 5Hospira Reports Second Quarter 2009 Results 53042 6Hospira Reports Second Quarter 2009 Results 53042 7Hospira Reports Second Quarter 2009 Results 53042 8Hospira Reports Second Quarter 2009 Results 53042 9Hospira Reports Second Quarter 2009 Results 53042 10Hospira Reports Second Quarter 2009 Results 53042 11Hospira Reports Second Quarter 2009 Results 53042 12Hospira Reports Second Quarter 2009 Results 53042 13Hospira Reports Second Quarter 2009 Results 53042 14Hospira Reports Second Quarter 2009 Results 53042 15Hospira Reports Second Quarter 2009 Results 53042 16Hospira Reports Second Quarter 2009 Results 53042 17Hospira Reports Second Quarter 2009 Results 53042 18Hospira Reports Second Quarter 2009 Results 53042 19Hospira Reports Second Quarter 2009 Results 53042 20Hospira Reports Second Quarter 2009 Results 53042 21Hospira Reports Second Quarter 2009 Results 53042 22Hospira Reports Second Quarter 2009 Results 53042 23Hospira Reports Second Quarter 2009 Results 53042 24Hospira Reports Second Quarter 2009 Results 53042 25Hospira Reports Second Quarter 2009 Results 53042 26Hospira Reports Second Quarter 2009 Results 53042 27Hospira Reports Second Quarter 2009 Results 53042 28American Academy of Dermatology to Hold Summer Scientific Meeting in Boston 53038 1
... - A Single Platform for Innovative ... true load-and-go productivity and maximized workflow. ... UF-100 for complete walkaway urinalysis. Two ... deliver utmost reliability. Ease of use ...
... throughput primary or backup instrument, this ... and reliability equal to or greater ... advanced technology of the AUTION JET ... reproducible and accurate results, limiting interference ...
... one of the 3 major naturally occurring ... In terms of estrogenic activity, estriol is ... is produced almost exclusively during pregnancy, and ... normal human fetus. During pregnancy, the production ...
Assay uses highly specific rabbit anti-estriol antibody reparation - negligible cross-reactivity with other estrogen metabolites. Excellent assay precision and reproducibility. Superior sensitivity ...
Medicine Products: